Oaktree Acquisition Corp. III Life Sciences (OACCW) Stock Overview
Explore Oaktree Acquisition Corp. III Life Sciences’s financial performance, market position, analyst ratings, and future outlook.
Oaktree Acquisition Corp. III Life Sciences (OACCW)
Key Financials
Key Financials
Market Cap
158.8M
P/E Ratio
37.91
EPS (TTM)
$0.27
ROE
0.03%
OACCW Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Oaktree Acquisition Corp. III Life Sciences's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of OACCW on the NASDAQ shows an RSI of 47.54, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.88 for the NASDAQ listing.
Key metrics behind Oaktree Acquisition Corp. III Life Sciences's NASDAQ-traded stock include a P/E ratio of 37.91 and a market capitalization of 158.8M. Combined with our AI analysis, these give both institutional and retail investors a clear view of OACCW on the NASDAQ.